|
KLF11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.85469434149854E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.12239995075925E-10 |
| Normal-vs-Stage2 |
4.20330000000524E-05 |
| Normal-vs-Stage3 |
2.88479995447233E-09 |
| Normal-vs-Stage4 |
2.42169999609132E-08 |
| Stage1-vs-Stage2 |
5.730200E-01 |
| Stage1-vs-Stage3 |
5.765600E-01 |
| Stage1-vs-Stage4 |
2.930200E-01 |
| Stage2-vs-Stage3 |
3.803800E-01 |
| Stage2-vs-Stage4 |
2.030800E-01 |
| Stage3-vs-Stage4 |
5.656600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.21299645275508E-11 |
| Normal-vs-AfricanAmerican |
5.96889999999739E-05 |
| Normal-vs-Asian |
2.22660000004371E-06 |
| Caucasian-vs-AfricanAmerican |
8.336200E-01 |
| Caucasian-vs-Asian |
8.975400E-01 |
| AfricanAmerican-vs-Asian |
7.782400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.98969996034748E-09 |
| Normal-vs-Female |
1.39479539029708E-11 |
| Male-vs-Female |
7.826000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.48929996007996E-09 |
| Normal-vs-Age(41-60Yrs) |
3.12072589991885E-12 |
| Normal-vs-Age(61-80Yrs) |
4.1864000044356E-08 |
| Normal-vs-Age(81-100Yrs) |
2.170200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.301200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.520400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.670020E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.649600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.449700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.667220E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.935800E-02 |
| Classical-VS-Follicular |
4.408600E-01 |
| Classical-VS-Other |
1.620810E-01 |
| Classical-VS-Normal |
2.92800006462812E-10 |
| Tall-VS-Follicular |
2.742400E-01 |
| Tall-VS-Other |
4.246400E-01 |
| Tall-VS-Normal |
7.48090001057022E-09 |
| Follicular-VS-Other |
3.221200E-01 |
| Follicular-VS-Normal |
1.38119999992803E-07 |
| Other-VS-Normal |
1.035290E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.34103839144473E-12 |
| Normal-vs-N1 |
7.56119999945071E-09 |
| N0-vs-N1 |
3.959400E-01 |
|
|
